| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tempest Therapeutics, Inc. (TPST) has 5 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. TPST is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.6K | $536.5K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 8, 2015 | Malley Thomas67 | Director | Buy | 5,000 | $28.50 | $142,500.00 | +4.3% | |
| Apr 8, 2015 | Aldrich Richard | Director | Buy | 2,500 | $29.97 | $74,925.00 | +12.6% | |
| Apr 8, 2015 | Young Jeffrey E | Chief Financial Officer | Buy | 300 | $29.93 | $8,979.00 | New | |
| Apr 2, 2015 | Dipp Michelle | Chief Executive Officer | Buy | 1,000 | $32.49 | $32,490.00 | +0.1% | |
| Jan 13, 2015 | Malley Thomas67 | Director | Buy | 35,000 | $50.00 | $1,750,000.00 | +42.8% |